Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Neoplasms of the CNS

  Free Subscription


12.04.2021

2 BMC Cancer
2 Cancer
2 Childs Nerv Syst
2 Eur J Cancer
2 Int J Cancer
6 Int J Radiat Oncol Biol Phys
2 J Neurooncol
1 J Neuropathol Exp Neurol
15 Neuro Oncol
3 Neuroradiology
4 Neurosurgery
2 PLoS One
1 Rev Neurol (Paris)


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Cancer

  1. AMIN S, Baine M, Meza J, Lin C, et al
    The impact of treatment facility type on the survival of brain metastases patients regardless of the primary cancer type.
    BMC Cancer. 2021;21:387.
    PubMed         Abstract available

  2. RADES D, Witteler J, Olbrich D, Trillenberg P, et al
    A prospective interventional study evaluating seizure activity during a radiotherapy course for high-grade gliomas (SURF-ROGG).
    BMC Cancer. 2021;21:386.
    PubMed         Abstract available


    Cancer

  3. HAJDU SI
    Pathfinders in oncology from the beginning of modern surgery of intracranial tumors to the introduction of the Pap smear.
    Cancer. 2020;126:2734-2749.
    PubMed         Abstract available

  4. KARSCHNIA P, Batchelor TT, Jordan JT, Shaw B, et al
    Primary dural lymphomas: Clinical presentation, management, and outcome.
    Cancer. 2020;126:2811-2820.
    PubMed         Abstract available


    Childs Nerv Syst

  5. BEDIOUI A, Rkhami M, Jemel N, Somrani K, et al
    About a rare pediatric case of myxoid meningioma.
    Childs Nerv Syst. 2021 Apr 7. pii: 10.1007/s00381-021-05156.
    PubMed         Abstract available

  6. SOLEMAN J, Dvir R, Ben-Sira L, Yalon M, et al
    MRI-based diagnosis and treatment of pediatric brain tumors: is tissue sample always needed?
    Childs Nerv Syst. 2021 Apr 5. pii: 10.1007/s00381-021-05148.
    PubMed         Abstract available


    Eur J Cancer

  7. DIMITRIOU F, Zaremba A, Allayous C, Kahler KC, et al
    Sustainable responses in metastatic melanoma patients with and without brain metastases after elective discontinuation of anti-PD1-based immunotherapy due to complete response.
    Eur J Cancer. 2021;149:37-48.
    PubMed         Abstract available

  8. KARSCHNIA P, Vogelbaum MA, van den Bent M, Cahill DP, et al
    Evidence-based recommendations on categories for extent of resection in diffuse glioma.
    Eur J Cancer. 2021;149:23-33.
    PubMed         Abstract available


    Int J Cancer

  9. KARALEXI MA, Dessypris N, Georgakis MK, Ryzhov A, et al
    Birth seasonality of childhood central nervous system tumors: Analysis of primary data from 16 Southern-Eastern European population-based registries.
    Int J Cancer. 2020;147:1252-1263.
    PubMed         Abstract available

  10. HE JB, Zhang X, Guo ZW, Liu MM, et al
    Ponatinib therapy in recurrent Philadelphia chromosome-positive central nervous system leukemia with T315I mutation after Allo-HSCT.
    Int J Cancer. 2020;147:1071-1077.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  11. RADONIC S, Besserer J, Meier V, Bley CR, et al
    A novel analytical population TCP model includes cell density and volume variations: application to canine brain tumor.
    Int J Radiat Oncol Biol Phys. 2021 Apr 7. pii: S0360-3016(21)00281.
    PubMed         Abstract available

  12. ZAYED S, Chen H, Ali E, Rodrigues GB, et al
    Is there a Role for Hypofractionated Thoracic Radiotherapy in Limited-Stage Small Cell Lung Cancer? A Propensity Score Matched Analysis.
    Int J Radiat Oncol Biol Phys. 2020 Jun 13. pii: S0360-3016(20)31249.
    PubMed         Abstract available

  13. LEE JW, Lim DH, Sung KW, Cho HW, et al
    Induction Chemotherapy Reduces Radiation Therapy Dose and Volume in the Treatment of Intracranial Germinoma: Results of the SMC-G13 Trial.
    Int J Radiat Oncol Biol Phys. 2020;108:649-656.
    PubMed         Abstract available

  14. BYUN HK, Yoon HI, Cho J, Shim KW, et al
    Optimization of Intracranial Germinoma Treatment: Radiotherapy Alone with Reduced Volume and Dose.
    Int J Radiat Oncol Biol Phys. 2020;108:657-666.
    PubMed         Abstract available

  15. ALVAREZ ANDRES E, Fidon L, Vakalopoulou M, Lerousseau M, et al
    Dosimetry-Driven Quality Measure of Brain Pseudo Computed Tomography Generated From Deep Learning for MRI-Only Radiation Therapy Treatment Planning.
    Int J Radiat Oncol Biol Phys. 2020;108:813-823.
    PubMed         Abstract available

  16. FABIANO S, Bangert M, Guckenberger M, Unkelbach J, et al
    Accounting for Range Uncertainties in the Optimization of Combined Proton-Photon Treatments Via Stochastic Optimization.
    Int J Radiat Oncol Biol Phys. 2020;108:792-801.
    PubMed         Abstract available


    J Neurooncol

  17. VAN DER MEER PB, Koekkoek JAF, van den Bent MJ, Dirven L, et al
    Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints.
    J Neurooncol. 2021 Apr 6. pii: 10.1007/s11060-021-03747.
    PubMed         Abstract available

  18. RUSTE V, Sunyach MP, Tanguy R, Jouanneau E, et al
    Synchronous brain metastases as a poor prognosis factor in clear cell renal carcinoma: a strong argument for systematic brain screening.
    J Neurooncol. 2021 Apr 10. pii: 10.1007/s11060-021-03751.
    PubMed         Abstract available


    J Neuropathol Exp Neurol

  19. STEPHEN NIX J, Ida CM
    What Every Neuropathologist Needs to Know: Practical Aspects and Pitfalls in Molecular Diagnosis of Brain Tumors.
    J Neuropathol Exp Neurol. 2021 Apr 9. pii: 6219399. doi: 10.1093.
    PubMed         Abstract available


    Neuro Oncol

  20. YU Y, Villanueva-Meyer J, Grimmer MR, Hilz S, et al
    Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas.
    Neuro Oncol. 2021 Apr 5. pii: 6211336. doi: 10.1093.
    PubMed         Abstract available

  21. SANTAGATA S, Ligon KL
    Prognostication for meningiomas: H3K27me3 to the rescue?
    Neuro Oncol. 2021 Apr 3. pii: 6209863. doi: 10.1093.
    PubMed        

  22. ROUX A, Tauziede-Espariat A, Zanello M, Peeters S, et al
    Imaging growth as a predictor of grade of malignancy and aggressiveness of IDH-mutant and 1p/19q-codeleted oligodendrogliomas in adults.
    Neuro Oncol. 2020;22:993-1005.
    PubMed         Abstract available

  23. TSANG DS, Schulte F
    Beyond the brain: Socioeconomic status and race in pediatric brain tumor survivorship.
    Neuro Oncol. 2021 Apr 3. pii: 6209877. doi: 10.1093.
    PubMed        

  24. LEE EQ, Selig W, Meehan C, Bacha J, et al
    Report of National Brain Tumor Society Roundtable Workshop on Innovating Brain Tumor Clinical Trials: Building on Lessons Learned from COVID-19 Experience.
    Neuro Oncol. 2021 Apr 2. pii: 6209406. doi: 10.1093.
    PubMed         Abstract available

  25. BOHM AK, DePetro J, Binding CE, Gerber A, et al
    In vitro modeling of glioblastoma initiation using PDGF-AA and p53-null neural progenitors.
    Neuro Oncol. 2020;22:1150-1161.
    PubMed         Abstract available

  26. COLO F, Larrouquere L, Rivoirard R, Loiseau H, et al
    Bevacizumab in progressive disseminated atypical choroid plexus papilloma in adults.
    Neuro Oncol. 2020;22:1046-1047.
    PubMed        

  27. SHI C, Ye Z, Han J, Ye X, et al
    BRD4 as a therapeutic target for nonfunctioning and growth hormone pituitary adenoma.
    Neuro Oncol. 2020;22:1114-1125.
    PubMed         Abstract available

  28. JAIN R, Johnson DR, Patel SH, Castillo M, et al
    "Real world" use of a highly reliable imaging sign: "T2-FLAIR mismatch" for identification of IDH mutant astrocytomas.
    Neuro Oncol. 2020;22:936-943.
    PubMed         Abstract available

  29. WICK A, Kessler T, Platten M, Meisner C, et al
    Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytoma.
    Neuro Oncol. 2020;22:1162-1172.
    PubMed         Abstract available

  30. FRAPPAZ D, Barritault M, Montane L, Laigle-Donadey F, et al
    MEVITEM - A Phase I/II of vismodegib + temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with Sonic Hedgehog pathway activation.
    Neuro Oncol. 2021 Apr 7. pii: 6213882. doi: 10.1093.
    PubMed         Abstract available

  31. MUKHERJEE S, Olson C, Dundar B, Sharma N, et al
    Erratum to: STEM-19. RESISTANCE IS FUTILE: UNDERSTANDING AND TARGETING THE CDK5-CREB1-MCL1 AXIS TO PREVENT RADIATION RESISTANCE IN GLIOMA STEM CELLS.
    Neuro Oncol. 2021 Apr 7. pii: 6214066. doi: 10.1093.
    PubMed        

  32. MUKHERJEE S, Schiltz G, Clutter M, Mishra R, et al
    Erratum to: DDIS-27. TARGETING ATP DOCKING AND P35/P25 BINDING OF CDK5 IN GLIOMA STEM CELLS USING SYNTHETIC INHIBITORS.
    Neuro Oncol. 2021 Apr 7. pii: 6214067. doi: 10.1093.
    PubMed        

  33. HORBINSKI C, McCortney K, Stupp R
    MGMT promoter methylation is associated with patient age and 1p/19q status in IDH-mutant gliomas.
    Neuro Oncol. 2021 Apr 8. pii: 6217333. doi: 10.1093.
    PubMed        

  34. WANIS HA, Moller H, Ashkan K, Davies EA, et al
    The incidence of major subtypes of primary brain tumours in adults in England 1995-2017.
    Neuro Oncol. 2021 Apr 9. pii: 6218679. doi: 10.1093.
    PubMed         Abstract available


    Neuroradiology

  35. PEER S, Saini J, Prasad C, Kulanthaivelu K, et al
    Utility of multiparametric pre-operative magnetic resonance imaging in differentiation of chordoid meningioma from the other histopathological subtypes of meningioma-a retrospective study.
    Neuroradiology. 2021 Apr 10. pii: 10.1007/s00234-021-02690.
    PubMed         Abstract available

  36. PIRKL CM, Nunez-Gonzalez L, Kofler F, Endt S, et al
    Accelerated 3D whole-brain T1, T2, and proton density mapping: feasibility for clinical glioma MR imaging.
    Neuroradiology. 2021 Apr 9. pii: 10.1007/s00234-021-02703.
    PubMed         Abstract available

  37. BHANDARI A, Sharma C, Ibrahim M, Riggs M, et al
    The role of 2-hydroxyglutarate magnetic resonance spectroscopy for the determination of isocitrate dehydrogenase status in lower grade gliomas versus glioblastoma: a systematic review and meta-analysis of diagnostic test accuracy.
    Neuroradiology. 2021 Apr 3. pii: 10.1007/s00234-021-02702.
    PubMed         Abstract available


    Neurosurgery

  38. YU X, Curry WT, Gerstner ER, Cahill DP, et al
    Commentary: Chimeric Antigen Receptor T-Cell Therapy: Updates in Glioblastoma Treatment.
    Neurosurgery. 2021 Apr 7. pii: 6214538. doi: 10.1093.
    PubMed        

  39. DONO A, Chandra A, Ballester LY, Esquenazi Y, et al
    Commentary: The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracranial Meningioma.
    Neurosurgery. 2021 Apr 7. pii: 6214539. doi: 10.1093.
    PubMed        

  40. RAHMAN A, Lozada-Martinez ID, Rahman S, Ataullah AHM, et al
    Letter: A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma.
    Neurosurgery. 2021 Apr 2. pii: 6209382. doi: 10.1093.
    PubMed        

  41. JIAN A, Jang K, Manuguerra M, Liu S, et al
    Machine Learning for the Prediction of Molecular Markers in Glioma on Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis.
    Neurosurgery. 2021 Apr 7. pii: 6214540. doi: 10.1093.
    PubMed         Abstract available


    PLoS One


  42. Correction: Assessment of Amide proton transfer weighted (APTw) MRI for pre-surgical prediction of final diagnosis in gliomas.
    PLoS One. 2021;16:e0250189.
    PubMed         Abstract available

  43. PROST DM, Merenzon MA, Gomez-Escalante JI, Primavera A, et al
    Effects of time to chemoradiation on high-grade gliomas from the Buenos Aires Metropolitan Area.
    PLoS One. 2021;16:e0249486.
    PubMed         Abstract available


    Rev Neurol (Paris)

  44. JACQUES A, Thomas L, Fenouil T, Fomekong F, et al
    Primary intracranial germinoma mimicking meningioma in an elderly patient.
    Rev Neurol (Paris). 2021 Mar 29. pii: S0035-3787(21)00463.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: